Ivermectin and Cancer: Why Researchers Are Studying an Antiparasitic Drug
Ivermectin has shown effects on cancer cells in the lab, but at levels far above what people can reach. Human evidence is very limited, and safety matters.
Supplement and pharmaceutical evidence, held to the same standard, on the same page.
Filtered by Preclinical Research · Clear filter
Ivermectin has shown effects on cancer cells in the lab, but at levels far above what people can reach. Human evidence is very limited, and safety matters.
Mebendazole, a long-used deworming drug, shows anticancer activity in lab models. Human data are limited and early, and liver and marrow effects matter.
Methylene blue is approved for one blood condition and studied in cancer cells and mice. No human trial shows it treats cancer, and it interacts with common medicines.